Unstable angina non ST elevation myocardial infarction: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 36: | Line 36: | ||
==[[Unstable angina treatment| Treatment]]== | ==[[Unstable angina treatment| Treatment]]== | ||
'''Pre-hospital Care :''' [[ | '''Pre-hospital Care :''' [[UA / NSTEMI prehospital care before onset| Before Onset]] | [[UA / NSTEMI prehospital care after onset| After Onset]] | ||
'''Immediate Management :''' | '''Immediate Management :''' | ||
[[Unstable angina / non ST elevation myocardial infarction immediate management | Overview]] | [[Unstable angina / NSTEMI oxygen therapy |Oxygen]] | [[Unstable angina/NSTEMI nitrate therapy |Nitrates]] | [[Unstable angina/NSTEMI analgesics | Analgesics]] | [[Unstable angina/NSTEMI beta blockers | Beta Blockers]] | [[Unstable angina / NSTEMI CCB therapy | Calcium Channel Blocker]] | [[UA/NSTEMI inhibitors of RAS | Inhibitors of Renin-Angiotensin-Aldosterone axis]] | [[Unstable angina / non ST elevation myocardial infarction immediate management | Overview]] | [[Unstable angina / NSTEMI oxygen therapy |Oxygen]] | [[Unstable angina/NSTEMI nitrate therapy |Nitrates]] | [[Unstable angina/NSTEMI analgesics | Analgesics]] | [[Unstable angina/NSTEMI beta blockers | Beta Blockers]] | [[Unstable angina / NSTEMI CCB therapy | Calcium Channel Blocker]] | [[UA/NSTEMI inhibitors of RAS | Inhibitors of Renin-Angiotensin-Aldosterone axis]] | [[UA/NSTEMI ACC/AHA guidelines for immediate management| ACC/AHA Guidelines for immediate management]] | ||
'''Antithrombin Therapy :''' [[Unstable angina / non ST elevation myocardial infarction anticoagulant therapy | Overview]] | [[Unstable angina / NSTEMI unfractionated heparin therapy |Unfractionated Heparin]] | [[Unstable angina / NSTEMI low molecular weight heparin therapy |Low Molecular Weight Heparin]] | [[Unstable angina / NSTEMI direct thrombin inhibitors therapy |Direct Thrombin Inhibitors]] | [[Unstable angina / NSTEMI factor Xa inhibitors therapy |Factor Xa Inhibitors]] | [[Unstable angina / NSTEMI long term anticoagulation therapy |Long Term Anticoagulation]] | [[Unstable angina / NSTEMI ACC/AHA guidelines for anticoagulation therapy|ACC/AHA Guidelines for Anticoagulation]] | '''Antithrombin Therapy :''' [[Unstable angina / non ST elevation myocardial infarction anticoagulant therapy | Overview]] | [[Unstable angina / NSTEMI unfractionated heparin therapy |Unfractionated Heparin]] | [[Unstable angina / NSTEMI low molecular weight heparin therapy |Low Molecular Weight Heparin]] | [[Unstable angina / NSTEMI direct thrombin inhibitors therapy |Direct Thrombin Inhibitors]] | [[Unstable angina / NSTEMI factor Xa inhibitors therapy |Factor Xa Inhibitors]] | [[Unstable angina / NSTEMI long term anticoagulation therapy |Long Term Anticoagulation]] | [[Unstable angina / NSTEMI ACC/AHA guidelines for anticoagulation therapy|ACC/AHA Guidelines for Anticoagulation]] | ||
| Line 55: | Line 55: | ||
[[Unstable angina / non ST elevation myocardial infarction medical regimen and use of medications | Medical Regimen]] | [[Unstable angina / non ST elevation myocardial infarction post-discharge follow-up | Post-Discharge Follow-Up]] | [[Unstable angina / non ST elevation myocardial infarction cardiac rehabilitation | Cardiac Rehabilitation]] | [[Unstable angina / non ST elevation myocardial infarction medical regimen and use of medications | Medical Regimen]] | [[Unstable angina / non ST elevation myocardial infarction post-discharge follow-up | Post-Discharge Follow-Up]] | [[Unstable angina / non ST elevation myocardial infarction cardiac rehabilitation | Cardiac Rehabilitation]] | ||
==[[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention | | ==Long-Term Medical Therapy and Secondary Prevention== | ||
[[ | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention |Overview]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy|Antiplatelet Therapy]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for beta blockers|Beta Blockers]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for inhibitors of the RAS|Inhibition Of The Renin-Angiotensin-Aldosterone System]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for nitroglycerin|Nitroglycerin Therapy]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for CCB|Calcium Channel Blockers]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy|Warfarin Therapy]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management|Lipid Management]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control|Blood Pressure Control]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus|Diabetes Mellitus]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation|Smoking Cessation]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management|Weight Management]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for Physical Activity|Physical Activity]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines patient education|Patient Education]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines influenza vaccination|Influenza Vaccination]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines depression|Depression]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines Nonsteroidal Anti-Inflammatory Drugs|Nonsteroidal Anti-Inflammatory Drugs]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy|Hormone Therapy]] | [[UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid|Antioxidant Vitamins and Folic Acid]] | ||
| [[ | |||
==Special Groups== | ==Special Groups== | ||
Revision as of 06:14, 15 July 2011
| Unstable angina pectoris | |
| ICD-10 | I20 |
|---|---|
| ICD-9 | 413 |
| DiseasesDB | 8695 |
| eMedicine | med/133 |
| MeSH | D000787 |
|
Unstable angina / NSTEMI Microchapters |
|
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
|
Special Groups |
|
Diagnosis |
|
Laboratory Findings |
|
Treatment |
|
Antitplatelet Therapy |
|
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
|
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
|
Mechanical Reperfusion |
|
Discharge Care |
|
Case Studies |
|
Unstable angina non ST elevation myocardial infarction On the Web |
|
FDA on Unstable angina non ST elevation myocardial infarction |
|
CDC onUnstable angina non ST elevation myocardial infarction |
|
Unstable angina non ST elevation myocardial infarction in the news |
|
Blogs on Unstable angina non ST elevation myocardial infarction |
|
to Hospitals Treating Unstable angina non ST elevation myocardial infarction |
|
Risk calculators and risk factors for Unstable angina non ST elevation myocardial infarction |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.; Smita Kohli, M.D.; Neil Gheewala, M.D. [3]
Synonyms and related keywords: angina at rest, rest angina, progressive angina, crescendo angina, accelerating angina, new-onset angina, pre-infarction angina, unstable angina pectoris, UAP, UA
Overview
Pathophysiology and Etiology
Unstable Angina | Non-ST Elevation Myocardial Infarction
Epidemiology and Demographics
Risk Factors
Risk Stratification | Guidelines for Early Risk Stratification | Guidelines for Risk Stratification before discharge
Natural history, Complications and Prognosis
Diagnosis
Differential diagnosis | Initial Therapy | History & Symptoms | Physical Examination | Biomarkers | Electrocardiogram | Chest X-Ray | Echocardiography | Coronary Angiography
Treatment
Pre-hospital Care : Before Onset | After Onset
Immediate Management : Overview | Oxygen | Nitrates | Analgesics | Beta Blockers | Calcium Channel Blocker | Inhibitors of Renin-Angiotensin-Aldosterone axis | ACC/AHA Guidelines for immediate management
Antithrombin Therapy : Overview | Unfractionated Heparin | Low Molecular Weight Heparin | Direct Thrombin Inhibitors | Factor Xa Inhibitors | Long Term Anticoagulation | ACC/AHA Guidelines for Anticoagulation
Antitplatelet Agents : Aspirin | Thienopyridines | Glycoprotein IIb/IIIa Inhibitor
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy
Mechanical Reperfusion : Initial Conservative Versus Initial Invasive Strategies | PCI | CABG
Complications of Bleeding and Transfusion
Overview | Incidence | Definitions | Predictors and Causes of Bleeding | Blood Transfusions | Prognosis | Prevention | Recommendations
Discharge Care
Medical Regimen | Post-Discharge Follow-Up | Cardiac Rehabilitation
Long-Term Medical Therapy and Secondary Prevention
Overview | Antiplatelet Therapy | Beta Blockers | Inhibition Of The Renin-Angiotensin-Aldosterone System | Nitroglycerin Therapy | Calcium Channel Blockers | Warfarin Therapy | Lipid Management | Blood Pressure Control | Diabetes Mellitus | Smoking Cessation | Weight Management | Physical Activity | Patient Education | Influenza Vaccination | Depression | Nonsteroidal Anti-Inflammatory Drugs | Hormone Therapy | Antioxidant Vitamins and Folic Acid
Special Groups
Women | Diabetic Patients | Post CABG Patients | Elderly | Chronic Kidney Disease | Drug and Substance Abusers | Prinzmetal's Angina | Cardiovascular Syndrome X
See Also
- The UA / NSTEMI Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines
- Chronic stable angina
- Non ST Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction
Sources
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[1]
- The ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction [2]
References
- ↑ Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS (2011). "2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e318212bb8b. PMID 21444888. Retrieved 2011-04-08. Unknown parameter
|month=ignored (help) - ↑ Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". Journal of the American College of Cardiology. 50 (7): e1–e157. doi:10.1016/j.jacc.2007.02.013. PMID 17692738. Retrieved 2011-04-11. Unknown parameter
|month=ignored (help)
External links
- The MD TV: Comments on Hot Topics, State of the Art Presentations in Cardiovascular Medicine, Expert Reviews on Cardiovascular Research
- Clinical Trial Results: An up to date resource of Cardiovascular Research
- Risk Assessment Tool for Estimating Your 10-year Risk of Having a Heart Attack - based on information of the Framingham Heart Study, from the United States National Heart, Lung and Blood Institute
- Heart Attack - overview of resources from MedlinePlus.
- Heart Attack Warning Signals from the Heart and Stroke Foundation of Canada
- Regional PCI for STEMI Resource Center - Evidence based online resource center for the development of regional PCI networks for acute STEMI
- STEMI Systems - Articles, profiles, and reviews of the latest publications involved in STEMI care. Quarterly newsletter.
- American College of Cardiology (ACC) Door to Balloon (D2B) Initiative.
- American Heart Association's Heart Attack web site - Information and resources for preventing, recognizing and treating heart attack.